What 4 Analyst Ratings Have To Say About AbbVie
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have published their opinions on AbbVie (NYSE:ABBV) stock, with one being bullish and three somewhat bullish. The average 12-month price target for AbbVie is $174.0, with a high of $182.00 and a low of $167.00. This average price target has increased by 0.87% over the past month.
September 29, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AbbVie has received positive ratings from four analysts over the past three months, with an average 12-month price target of $174.0. This target has increased by 0.87% over the past month.
The positive ratings from the analysts and the increase in the average price target over the past month indicate a bullish sentiment towards AbbVie. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100